CIMT 2010 Annual Meeting date will take place from the 26.-28.5.2010.
Download the program. [PDF, 3.5 MB]
It will be an unique interdisciplinary event representing all fields connected to the the development of cancer immunotherapies. From basic immunology, to translational research to clinical trials, immune monitoring and regulatory aspects, we will explore interrelationships between the fields aiming to facilitate knowledge transfer. We thereby hope to improve and actuate the development of new therapies for cancer.
Download the program. [PDF, 3.5 MB]
It will be an unique interdisciplinary event representing all fields connected to the the development of cancer immunotherapies. From basic immunology, to translational research to clinical trials, immune monitoring and regulatory aspects, we will explore interrelationships between the fields aiming to facilitate knowledge transfer. We thereby hope to improve and actuate the development of new therapies for cancer.
Plenary Sessions CIMT 2010 Annual Meeting:
- Tumor Vaccination: J.B. Haanen (Amsterdam); K. Rezvani (London); M. Frohlich (Dendreon, Seattle)
- Cooperation Partners for Vaccination Therapies: J. Allison (New York); A. Ribas (Los Angeles); H. Chen (Bethesda, NCI)
- Cellular Therapies: A. Mackensen (Erlangen); J. Barrett (Bethesda); M. Heemskerk (Leiden)
- Immunemonitoring: M.-L. (Nora) Disis (Washington); V. Appay (Paris); W. Zou (Ann Arbor)
- Chemo-Immunotherapy: L. Zitvogel (Paris); D. Gabrilovitch (Tampa); M. Dhodapkar (Yale)
- Poised, Suppressed, Tolerized – Mechanisms of Immunity: J. S. Bromberg (New York)
- Regulation – Challenges for Translation: U. Kalinke (Hannover); S. Khleif (Bethesda); R. K. Puri (FDA CBER); C. Schneider (PEI, Langen)
Short Talk Presentations
CIMT 2010 will give 30 authors of accepted abstracts the opportunity to present their data in a short talk. The six sessions will be chaired by experts in the field.Guided Poster Sessions
We will again organize a poster exhibition with guided poster sessions on all aspects relevant for cancer immunotherapy. Besides the subject mentioned above we will also cover:- Cancer Genomics
- New Targets
- Antibodies in Cancer Therapy
- Innate Immunity
- Tumor Biology
- Tumor Models
- Enhancing Immunity
Industry Exhibition
We will once again organize a lively industry exhibition focused on companies relevant for research in the field.Satellite Workshops
Having already built a tradition of industry satellite workshops we will yet again provide you with opportunities to hear about the newest developments in flowcytoemtry and other immunoassays.2010 Program Committee Members:
- Prof. Dr. Giorgio Parmiani (Milan)
Unit of immune-biotherapy of melanoma and solid tumors
Fondazione Centro san Raffaele del Monte Tabor
Building DIBIT
via Olgettina, 58
IT-20132 Milano
ITALY - Prof. Dolores Schendel, PhD (Munich)
Helmholtz Zentrum München
Institut für Molekulare Immunologie (IMI)
Marchioninistraße 25
D-81377 München
Tel: 089 / 7099 - 301
Fax: 089 / 7099 – 300
Email: schendel@helmholtz-muenchen.de - Prof. Dr. G. Pawelec, (Editor-in-Chief CII, Tübingen)Zentrum für Medizinische Forschung
Sektion Transplantationsimmunologie/Immunhämatologie
Medizinische Klinik II
Waldhörnle Strasse 22
D- 72072 Tübingen / Derendingen
Tel.: 07071-29 82805
Fax.: 07071-29 4677
Pawelec Group
Email: graham.pawelec@uni-tuebingen.de - Prof. Dr. Freda Stevenson (Southampton)
Molecular Immunology Group
Cancer Sciences Division
School of Medicine, University of Southampton
MP824, Southampton General Hospital
Southampton SO16 6YD
United Kingdom - Prof. Dr. Christian Ottensmeier (Southampton)
Cancer Sciences Division
Southampton University Hospitals
Tremona Road
Southampton SO16 6YD
United Kingdom - Prof. Dr. Wolfgang Herr, Mainz
JGU Universitätsmedizin Mainz, Innere Medizin
Tel.: 0 6131 172710
Fax: 0 6131 176678
Email: herr@3-med.klinik.uni-mainz.de
- Axel Hoos, M.D., Ph.D, CRI-CVC
Co-Chairman, CVC Executive Committee; Program leader in Immunology/Oncology at Bristol-Myers Squibb
Bristol Myers Squibb Inc.
5 Research Parkway,
Wallingford, P.O. Box 5100,
CT 06492-7600, USA
Mail: axel.hoos@bms.com
URL: www.cancerresearch.org/programs... - Antoine Tesniere, MD, PhD., Paris
INSERM Unit U848, "Apoptosis, Cancer & Immunity"
Institut Gustave Roussy
Pavillon de Recherche 1
39, rue Camille Desmoulins
F-94805 VILLEJUIF Cedex
France
Tel: + 33 (0)1.42.11.52.16
Fax: + 33 (0)1.42.11.66.65
URL : www.igr.fr/index.php?p_id=1072 - Prof. Dr. Hansjoerg Schild, (FZI delegate, Mainz)
JGU Universitätsmedizin Mainz, Innere Medizin
Director of Institute for Immunology
University of Mainz
Obere Zahlbacher Str. 67
D-55131 Mainz
Germany
Tel: 6131 39 37288
Fax: 6131 39 35688
E-Mail: schild@uni-mainz.de - Dr. S. Kreiter (Coordinator, Mainz)
III. Medizinische Klinik und Poliklinik
Johannes Gutenberg-Universität Mainz
Langenbeckstr. 1
55131 Mainz - Regulatory Research Group represented by:
- Dr. Harpreet Singh (Immatics, Tübingen)
- CIP represented by its board members:
- Dr. C. Britten (Mainz)
III. Medizinische Klinik und Poliklinik
Johannes Gutenberg-Universität Mainz
Langenbeckstr. 1
55131 Mainz - Cecile Gouttefangeas, PhD (Tuebingen)
Department of Immunology
University of Tuebingen
Tuebingen, Germany
Email: cecile.gouttefangeas@uni-tuebingen.de
- Sjoerd H. van der Burg, PhD (Leiden)
Sjoerd H. van der Burg, PhD
Department for Clinical Oncology
Leiden University Medical Center
Leiden, The Netherlands
Email: shvdburg@lumc.nl
